Welcome : Guest

CLINICAL NUTRITION PRODUCTS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Clinical Nutrition Products in US$ Million. The Global market is analyzed by the following segments: Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 65 companies including many key and niche players such as -

Abbott Nutrition
Baxter International, Inc.
B. Braun Melsungen AG
Claris Lifesciences Ltd.
Fresenius Kabi AG

Click here to request a full list of companies covered in the report...

Code: MCP-6353
Price: $4950
Companies: 65
Pages: 387
Date: February 2017
Market Data Tables: 165
 



TABLE OF CONTENTS


  CLINICAL NUTRITION PRODUCTS (Complete Report) Pages : 387   | $4950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Clinical Nutrition Products: Essential for Addressing Disease-Related
  Malnutrition.....II-1
1$100
   Market Outlook.....II-21$100
   Developed Regions Lead, Emerging Markets to Spearhead Future Growth.....II-31$100
   Infant Nutrition Market: The Leading Segment with High Growth Potential.....II-4 1$100
   Table 1: Global Infant Nutrition Market (2016): Percentage Breakdown of Value Sales by Segment - Dried Food, Follow-On Formula, Prepared Food, Special Formula, Standard Formula and Toddler Formula (includes corresponding Graph/Chart).....II-51$350
   Need for Nutritional Support – Essential for Preterm Infants.....II-6
Inadequate Physiological Development Raises Need for Tube Feeding in Infants.....II-6
Nutritional Needs of Premature Infants: Mix of PN & EN Nutrition Emerges as Common
  Practice.....II-6
1$100
   Parenteral Nutrition: Providing Essential Nutrition through Intravenous Feeding.....II-7 1$100
   Table 2: Global Parenteral Nutrition Products Market (2016): Percentage Breakdown of Revenues by Product Category (includes corresponding Graph/Chart).....II-8
Asia-Pacific to Drive Future Growth in PN Products Market.....II-8
1$350
   Enteral Nutrition – Preferred Approach Compared to Parenteral Nutrition
  Products.....II-9
1$100
   Standard Enteral Nutrition Formulations Lead EN Products Market.....II-10
Table 3: Global Enteral Nutrition Products Market by Product Type (2016): Percentage Breakdown of Revenues for Disease-Specific Products and Standard Products (includes corresponding Graph/Chart).....II-10
1$350
   Oncology Applications Leads EN Market.....II-11
Hospitals & Long-term Care Facilities: The Major Users of EN Products.....II-11
1$100
   A Highly Competitive Marketplace.....II-12
Table 4: Leading Players in the Global Clinical Nutrition Market (2016E): Percentage Breakdown of Value Sales for Abbott Nutrition, Danone, Fresenius Kabi, Nestle and Others (includes corresponding Graph/Chart).....II-12
1$350
   Table 5: Leading Manufacturers in the Global Infant Nutrition Market (2016E): Percentage Breakdown of Revenues for Abbott Nutrition, Danone, Mead Johnson, Nestlé and Others (includes corresponding Graph/Chart).....II-13
Enteral Nutrition Market.....II-13
Table 6: Leading Manufacturers in the Global Enteral Nutrition Market (2016E): Percentage Breakdown of Revenues for Abbott, Danone, Fresenius Kabi, Mead Johnson, Nestlé and Others (includes corresponding Graph/Chart).....II-13
1$350
   Parenteral Nutrition Market.....II-14
Table 7: Leading Manufacturers in the Global Parenteral Nutrition Market (2016E): Percentage Breakdown of Revenues for B. Braun, Baxter International, Fresenius Kabi, ICU Medical and Others (includes corresponding Graph/Chart).....II-14
1$350
   Sustained Increase in Healthcare Spending Bodes Well for Clinical Nutrition
  Market.....II-15
Table 8: Healthcare Spending as % of GDP by Geographic Region (2016) (includes corresponding Graph/Chart).....II-15
1$350
   Table 9: Top Countries with the Highest Per Capita Healthcare Spending (2014) (includes corresponding Graph/Chart).....II-161$350
   Aging Worldwide Population: Rising Need for Added Nutritional Support to Propel Market
  Growth.....II-17
1$100
   Table 10: Global Aging Population in Select Regions/ Countries: Population of 60+ Individuals in ‘000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart).....II-181$350
   Table 11: Elderly Population (60+ Years) as a Percentage of Total Population (2015 & 2050) (includes corresponding Graph/Chart).....II-191$350
   Table 12: Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart).....II-20
Rising Incidence of Chronic Diseases to Kindle Market Growth.....II-20
1$350
   Cancer – The Major Chronic Illness Requiring Clinical Nutrition Support.....II-21 1$100
   Table 13: Worldwide Incidence of Cancer: Number of New Cases Diagnosed for the Years 2013, 2020 & 2030 (includes corresponding Graph/Chart).....II-221$350
   Table 14: New Cancer Cases in the World by Affected Site (2012) (In Thousands) (includes corresponding Graph/Chart).....II-23

Table 15: Common Cause of Cancer Deaths Worldwide - Number of Deaths due to Select Types of Cancer for 2015 (includes corresponding Graph/Chart).....II-23
1$350
   Critical Nutrition Products Vital for Preventing Malnutrition in Diabetics.....II-24 1$100
   Table 16: Diabetes Prevalence Worldwide by Region: Number of Adults (20-79 Years) with Diabetes in 2015 and 2040 (includes corresponding Graph/Chart).....II-251$350
   Table 17: Global Prevalence (%) of Diabetes in Adults (20-79) by Region: 2015 & 2040 (includes corresponding Graph/Chart).....II-26

Table 18: Global Prevalence of Diabetes by Gender (2015 & 2040): Number of Adults Diagnosed with Diabetes (in Million) for Men and Women (includes corresponding Graph/Chart).....II-26
1$350
   Table 19: Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2015 & 2040 (includes corresponding Graph/Chart).....II-27
Persistent Threat of HIV/AIDS Infection: An Opportunity for Medical Nutrition
  Market.....II-27
1$350
   Some Significant HIV Statistics by Region: 2015.....II-28 1$100
   Table 20: Global Prevalence of HIV Infection in 2015 by Region (in Millions) (includes corresponding Graph/Chart).....II-291$350
   Table 21: New HIV Infections Worldwide by Geographic Region for 2015 (in Thousands) (includes corresponding Graph/Chart).....II-301$350
   Table 22: Global AIDS-Related Deaths by Geographic Region for the Year 2015 (includes corresponding Graph/Chart).....II-31
Clinical Nutrition in Treatment of Malnutrition: Significant Growth
  Opportunities.....II-31
1$350
   Non-volitional Nutritional Support Therapy: Vital for Combating Malnutrition during
  Hospitalization.....II-32
1$100
   Shift towards Home Care Boosts Demand for Clinical Nutrition Products.....II-33 2$200
   Table 23: Trend towards Home Healthcare to Propel Home Clinical Nutrition Market – Global Home Healthcare Revenues (in US$ Billion) for the Years 2016, 2018 & 2020 (includes corresponding Graph/Chart).....II-35
Changing Health and Social Care Factors Favor Home Enteral Feeding.....II-35
1$350
   Rising Number of Premature Births Drives Infant Clinical Nutrition Products
  Market.....II-36
Preterm Birth Statistics from WHO.....II-36
1$100
   Table 24: Percentage of Preterm Births by Region: 2012 (includes corresponding Graph/Chart).....II-371$350
   Table 25: Top Ten Countries with the Highest Number of Preterm Births (2012) (includes corresponding Graph/Chart).....II-38

Table 26: Top Ten Countries with the Highest Rates of Preterm Births (per 100 Live Births): 2012 (includes corresponding Graph/Chart).....II-38
1$350
   Demand for Personalized Medicine to Bode Well for Clinical Nutrition Products
  Market.....II-39
Product Innovations Blur the Lines between Medicine and Foods.....II-39
1$100
   Surging Demand for Omega-3 Fatty Acids-Fortified Clinical Nutrition Products.....II-40
Advances in Enteral Feeding Devices: Positive Outlook for Enteral Nutrition
  Market.....II-40
2$200
   Rising Incidence of Pediatric Crohn's Disease Fuels Enteral Nutrition Market.....II-42
Specialized Formula Products Inundate the Market.....II-42
Soy-based Infant Formula Gains Popularity.....II-42
1$100
   Pre-mixed IV Solutions: A Step towards Safer Medication Practices.....II-43
Growing Demand for Low-Cost Parenteral Nutrition Solutions.....II-43
1$100
   Rising Preference for Multi-Chamber Bags to Lower Cost of Parenteral Nutrition
  Therapy.....II-44
Increasing Popularity of Intravenous Vitamin C for Cancer Treatment.....II-44
Infection Control: A Prime Concern in Parenteral Nutrition.....II-44
1$100
   Complacency of Hospitals & Worker/Patient Safety: A Key Issue.....II-45
Favorable Clinical Findings Strengthens Prospects for Enteral Nutrition.....II-45
1$100
   Rising Preference for Enteral Nutrition – A Threat to Parenteral Nutrition
  Market.....II-46
1$100
   Advantages and Disadvantages of Enteral Nutrition over Parenteral Nutrition.....II-47
Major Challenges Confronting Medical Nutrition Products’ Marketers.....II-47
1$100
   Barriers to Widespread Adoption of Clinical Nutrition Products.....II-48
Reasons for Not Prescribing Clinical Nutrition Products.....II-48
1$100
   Clinical Nutrition: An Introduction.....II-49
Diseases Indicating Administering of Clinical Nutrition.....II-49
1$100
   Advantages of Clinical Nutrition.....II-50
Classification of Clinical Nutrition Products.....II-50
Infant Nutrition Products.....II-50
1$100
   Table 27: Nutrient Specifications for Infant Formulas (per 100kcal).....II-511$350
   List of Infant Nutrition Products.....II-521$100
   Types of Infant Nutrition Products.....II-53
Specialized Milk-Based Formulas.....II-53
Soy-based Infant Formula.....II-53
Amino Acid-based Formulas.....II-53
Probiotic Infant Formulas.....II-53
1$100
   Prebiotics in Infant Nutrition.....II-54
Exempt Infant Formulas.....II-54
1$100
   Human Milk Oligosaccharides.....II-55
Nutrition Products for Preterm Infants.....II-55
Premature Infant Formula.....II-55
Transitional Formulas.....II-55
1$100
   Human Milk Fortifiers.....II-56
Metabolic Infant Formulas.....II-56
Follow-up or Follow-on Formulas.....II-56
Enteral Administration of Infant Formulas in Neonatal Intensive Care and General
  Healthcare Settings.....II-56
Nipple Feeding.....II-56
1$100
   Tube Feeding.....II-57
Enteral Nutrition Products.....II-57
1$100
   Table 28: Daily Electrolyte Requirements for Enteral Nutrition.....II-58

Table 29: Daily Trace Element Requirement for Enteral Nutrition.....II-58
1$350
   Table 30: Daily Vitamin Requirements for Enteral Nutrition.....II-59

Table 31: Daily Trace Element Requirements Enteral Nutrition in Infants.....II-59

Table 32: Daily Vitamin Requirements for Enteral Nutrition in Infants.....II-59
1$350
   Enteral Nutrition by Age.....II-60
Enteral Nutrition for Patients aged 21 and older.....II-60
Enteral Nutrition for Patients below 21 Years.....II-60
Various Types of Enteral Feeding or Tube Feeding.....II-60
What Constitutes Enteral Nutrition Diets?.....II-60
1$100
   Home-Made Diets.....II-61
Commercial Enteral Formulas.....II-61
Elemental Formulas.....II-61
Oligomeric Formulas.....II-61
Polymeric Formulas.....II-61
1$100
   Special Formulas.....II-62
Pulmonary Formulas.....II-62
Liver Formulas.....II-62
1$100
   Renal Formulas.....II-63
Diabetes Formulas.....II-63
Gastrointestinal Dysfunction Formulas.....II-63
Immuno-modulatory Formulas.....II-63
Enteral Nutrition in Patients with Acute Renal Failure (ARF).....II-63
1$100
   Table 33: Nutritional Requirements in Patients with ARF.....II-64
Enteral Nutrition in Conservatively Treated Patients with Chronic Renal Failure
  (CRF).....II-64
Table 34: Recommendations for Protein Supply in Adult CRF Patients (in g/kgBW/day).....II-64
1$350
   Table 35: Mineral Requirements for Patients with CRF.....II-65
Enteral Nutrition in Haemodialysis Patients.....II-65
Enteral Nutrition in Chronic Ambulatory Peritoneal Dialysis (CAPD) Patients.....II-65
Table 36: Recommendations for Protein and Energy Supply in Adult Patients on Routine Hemodialysis and CAPD.....II-65
1$350
   Table 37: Mineral Requirements of Patients on Haemodialysis and Chronic Ambulatory Peritoneal Dialysis.....II-66
Complications of Enteral Feeding.....II-66
Complications Associated with Enteral Tube Feeding.....II-66
3$350
   Parenteral Nutrition.....II-69
Sources of Parenteral Solutions.....II-69
Routes of Administration.....II-69
1$100
   Types of Parenteral Nutrition Solutions.....II-70
Total Parenteral Nutrition (TPN).....II-70
1$100
   Table 38: Daily Requirements for Total Parenteral Nutrition (TPN) in Adults.....II-71

Table 39: Daily Recommended Parenteral Nutritional Intakes for Newborns.....II-71
1$350
   TPN Formulation.....II-721$100
   Partial Parenteral Nutrition (PPN).....II-73
Home Parenteral Nutrition.....II-73
Parenteral Nutrition Formulations.....II-73
Standard Solutions.....II-73
Three-in-One Standard Bags.....II-73
1$100
   Two-in-one Standard Bags.....II-74
Individual Solutions.....II-74
Non-Standard Solutions.....II-74
Classification of Parenteral Nutrition by Type of Nutrients.....II-74
Amino Acids.....II-74
1$100
   Carbohydrates.....II-75
Lipids.....II-75
Minerals & Electrolytes.....II-75
1$100
   Table 40: Daily Electrolyte Requirements for Parenteral Nutrition.....II-76
Micronutrients.....II-76
Vitamins.....II-76
1$350
   Table 41: Daily Vitamin Requirements for Parenteral Nutrition.....II-77
Trace Elements.....II-77
1$350
   Table 42: Daily Trace Element Requirement for Parenteral Nutrition.....II-78
Large and Small Volume Parenteral Solutions.....II-78
Large Volume Parenteral (LVP) Solutions.....II-78
1$350
   Small Volume Parenteral (SVP) Solutions.....II-79
IV Fat Emulsions – Enabling Maintenance of Bodyweight.....II-79
1$100
   Nestlé Health Science Introduces Compleat® Range of Tube-Feeding Formulas.....II-80
Fresenius Kabi Unveils IVFE Smoflipid® for Adults.....II-80
Otsuka Pharmaceutical Factory Gains Approval for ELNEOPA-NF Injection.....II-80
B. Braun Medical Unveils Clinical Nutrition 360 TPN Portfolio.....II-80
B. Braun Medical Introduces Nutrilipid® 20% for Parenteral Nutrition Therapy.....II-80
Otsuka Introduces HINE E-GEL Concentrated Liquid Nutrition Product.....II-80
1$100
   Fresenius Kabi Obtains FDA Approval for Perikabiven® and Kabiven®.....II-81
B. Braun Obtains FDA Approval for Nutrilipid® 20% for Parenteral Nutrition.....II-81
1$100
   ICU Medical Acquires Pfizer’s Hospira Infusion Therapy Business.....II-82
OP2Labs Acquires Provide Nutrition.....II-82
Abbott and Vietnam’s Ministry of Health Forge Strategic Partnership.....II-82
Baxter International Gains Marketing Approval for NUMETA G13E PN Product.....II-82
Nestlé Japan Acquires Ajinomoto’s Tube Feeding Business.....II-82
Linde Group Takes Over American HomePatient.....II-82
1$100
   Epic Health Services Takes Over Option 1 Healthcare Solutions.....II-83
Baxter Inks Global Licensing and Distribution Agreement with Laboratoire
  Aguettant.....II-83
Pfizer Acquires Hospira.....II-83
Nestlé Sets Up Health Science Manufacturing Plant.....II-83
Baxter Recalls Select Lots of Parenteral Nutrition Products.....II-83
ITH Pharma Recalls Lipid Phase Parenteral Nutrition Products.....II-83
Abbott Receives Approval for ENEVO™ Liquid for Enteral Use.....II-83
1$100
   Nestlé to Construct Infant Formula Plant in Mexico.....II-84
Abbott Inaugurates Nutrition Production Facility in Haiti.....II-84
Baxter Recalls Select Lots of Premix Parenteral Nutrition Products.....II-84
Baxter Collaborates with JW Holdings for Omega 3 Lipids.....II-84
Mead Johnson Establishes New Manufacturing and Research & Development Complex.....II-84
1$100
   Abbott Nutrition (US).....II-85
Baxter International, Inc. (US).....II-85
1$100
   B. Braun Melsungen AG (Germany).....II-86
Claris Lifesciences Ltd. (India).....II-86
Claris Otsuka Private Ltd. (India).....II-86
Fresenius Kabi AG (Germany).....II-86
1$100
   Groupe Danone (France).....II-87
Nutricia North America (US).....II-87
1$100
   Huarui Pharmaceutical Co., Ltd. (China).....II-88
ICU Medical, Inc. (US).....II-88
1$100
   Mead Johnson Nutrition Company (US).....II-89
Meiji Co., Ltd. (Japan).....II-89
1$100
   Nestlé Health Science S.A (Switzerland).....II-90
Otsuka Pharmaceutical Factory, Inc. (Japan).....II-90
1$100
   Table 43: World Recent Past, Current and Future Analysis for Clinical Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-911$350
   Table 44: World Historic Review for Clinical Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-921$350
   Table 45: World 14-Year Perspective for Clinical Nutrition Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-931$350
   Table 46: World Recent Past, Current and Future Analysis for Enteral Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-941$350
   Table 47: World Historic Review for Enteral Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-951$350
   Table 48: World 14-Year Perspective for Enteral Nutrition Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-961$350
   Table 49: World Recent Past, Current and Future Analysis for Infant Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-971$350
   Table 50: World Historic Review for Infant Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-981$350
   Table 51: World 14-Year Perspective for Infant Nutrition Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-991$350
   Table 52: World Recent Past, Current and Future Analysis for Parenteral Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-1001$350
   Table 53: World Historic Review for Parenteral Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-1011$350
   Table 54: World 14-Year Perspective for Parenteral Nutrition Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-1021$350
   A. Market Analysis.....III-1
Market Overview.....III-1
Aging Population Fuels Need for Clinical Nutrition.....III-1
1$75
   Table 55: Aging Population in the US (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-21$200
   Rising Incidences of Chronic Diseases Heightens Need for Clinical Nutrition
  Products.....III-3
Cancer Statistics in the US.....III-3
1$75
   Table 56: Estimated Number of New Cancer Cases in the US by State for 2017 (includes corresponding Graph/Chart).....III-41$200
   Table 57: Estimated Number of New Cancer Cases in the US by Gender and Affected Site for 2017 (includes corresponding Graph/Chart).....III-51$200
   Table 58: Estimated Number of Cancer-Related Deaths in the US by Gender and Body Site for 2017 (includes corresponding Graph/Chart).....III-61$200
   Rising Prevalence of Diabetes Mellitus in North America.....III-7
Table 59: Diabetes and Population Statistics in North America and Caribbean Region (2015 & 2040) (includes corresponding Graph/Chart).....III-7
1$200
   Table 60: Diabetes Statistics in the US (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) (includes corresponding Graph/Chart).....III-8
An Insight into Infant Nutrition Market.....III-8
Table 61: Infant & Toddler Nutrition Market in the US (2016): Percentage Breakdown of Value Sales by Segment (includes corresponding Graph/Chart).....III-8
1$200
   Clinical Nutrition – Vital for Preterm Infants.....III-9 1$75
   Table 62: Preterm Birth Rate (%) in the US by State for 2015.....III-101$200
   Table 63: Preterm Birth Rate (%) in the US by Race/Ethnicity for 2014 and 2015 (includes corresponding Graph/Chart).....III-111$200
   Table 64: Preterm Birth Rate (%) in the US by Gestational Age for 2014 and 2015 (includes corresponding Graph/Chart).....III-12
Strategic Innovations to Buoy Consumer Demand.....III-12
1$200
   Human Breast Milk-Like Infant Formulas to Gain Popularity.....III-13
Competition.....III-13
Table 65: Leading Players in the US Infant Formula Market (2016): Percentage Breakdown of Value Sales for Abbott, Mead Johnson, Nestle, and Others (includes corresponding Graph/Chart).....III-13
1$200
   Enteral Nutrition Market: Aging Population to Stimulate Growth.....III-14
Home Healthcare Fuels Demand for Home Enteral Nutrition Products.....III-14
1$75
   Enteral Nutrition Therapy to Treat Adult Malnutrition: Opportunities for
  Growth.....III-15
Reimbursement Scenario for Enteral Nutrition Therapy.....III-15
ENT Coverage under Part A.....III-15
1$75
   ENT Coverage under Part B.....III-161$75
   Reimbursements for Enteral Nutrients.....III-17
Parenteral Nutrition Market: An Overview.....III-17
Medicare Coverage for Parenteral Nutrition Therapy.....III-17
1$75
   Reimbursement Regulations to Hamper Market Growth.....III-181$75
   Shift towards Enteral Nutrition Therapies – A Threat to Parenteral Nutrition
  Market.....III-19
Advantages and Disadvantages of Enteral Nutrition over Parenteral
  Nutrition.....III-19
A.S.P.E.N. Practice Guidelines for Parenteral Nutrition.....III-19
1$75
   A.S.P.E.N. Guidelines for Parenteral Nutrition (as of 2004).....III-201$75
   Product Launches.....III-211$75
   Strategic Corporate Developments.....III-221$75
   Key Players.....III-233$225
   B. Market Analytics.....III-26
Table 66: US Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-26
1$200
   Table 67: US Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-271$200
   Table 68: US 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-281$200
   A. Market Analysis.....III-29
Current and Future Analysis.....III-29
Rising Incidence of Chronic Diseases: A Major Growth Driver.....III-29
Table 69: New Cancer Cases (in Thousands) in Canada by Gender for 2015 and 2016 (includes corresponding Graph/Chart).....III-29
1$200
   Table 70: Age-Standardized Incidence Rate (Per ‘000 People) in Canada by Gender and Type of Cancer – 2016 (includes corresponding Graph/Chart).....III-301$200
   Table 71: New Cancer Cases in Canada by Gender and Affected Site for 2016 (includes corresponding Graph/Chart).....III-311$200
   Table 72: New Cancer Cases in Canada by Province for 2016 (includes corresponding Graph/Chart).....III-321$200
   Table 73: New Cancer Cases in Canada by Age Group for 2016 (includes corresponding Graph/Chart).....III-331$200
   Table 74: Cancer Related Deaths in Canada by Gender and Affected Site for 2016 (includes corresponding Graph/Chart).....III-341$200
   Table 75: Cancer Related Deaths in Canada by Age Group for 2016 (includes corresponding Graph/Chart).....III-35

Table 76: Diabetes Statistics in Canada (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) (includes corresponding Graph/Chart).....III-35
1$200
   Table 77: Aging Population in Canada (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-361$200
   B. Market Analytics.....III-37
Table 78: Canadian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-37
1$200
   Table 79: Canadian Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-381$200
   Table 80: Canadian 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-391$200
   A. Market Analysis.....III-40
Market Overview.....III-40
Rising Incidence of Chronic Diseases – A Prime Growth Driver.....III-40
1$75
   Table 81: Cancer Incidence and Number of Cancer-Related Deaths among Japanese Men and Women for 2015 (includes corresponding Graph/Chart).....III-41

Table 82: Diabetes Statistics in Japan (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and Number of Children with Type 1 diabetes (in ‘000s) (includes corresponding Graph/Chart).....III-41
1$200
   Strategic Corporate Developments.....III-42
Key Players.....III-42
2$150
   B. Market Analytics.....III-44
Table 83: Japanese Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-44
1$200
   Table 84: Japanese Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-451$200
   Table 85: Japanese 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-461$200
   A. Market Analysis.....III-47
Market Overview.....III-47
An Overview of Enteral Feeding Market in Europe.....III-47
1$75
   Prospering Enteral Nutrition Market: New Avenues for Ingredient Suppliers.....III-48
Surging Interest in Home Healthcare: Gains for Enteral Nutrition Market.....III-48
1$75
   Aging Population & Rising Incidence of Chronic Diseases to Spur Growth.....III-49
Aging Statistics.....III-49
Table 86: Aging Population in Europe by Region (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-49
1$200
   Table 87: Aging Population in Europe by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-50
Cancer Trends.....III-50
1$200
   Table 88: Number of New Cancer Cases in Europe (2012-2030) (In Million) (includes corresponding Graph/Chart).....III-51

Table 89: Cancer Incidence in Europe by Site: 2012 (in Thousands) (includes corresponding Graph/Chart).....III-51
1$200
   Prevalence of Diabetes Mellitus in Europe.....III-52
Table 90: Diabetes and Population Statistics in Europe (2015 & 2040) (includes corresponding Graph/Chart).....III-52
1$200
   Table 91: Diabetes Statistics in Europe (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-531$200
   B. Market Analytics.....III-54
Table 92: European Recent Past, Current and Future Analysis for Clinical Nutrition Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-54
1$200
   Table 93: European Historic Review for Clinical Nutrition Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-551$200
   Table 94: European 14-Year Perspective for Clinical Nutrition Products by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-561$200
   Table 95: European Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-571$200
   Table 96: European Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-581$200
   Table 97: European 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-591$200
   A. Market Analysis.....III-60
Current and Future Analysis.....III-60
An Insight into Enteral Nutrition Market.....III-60
Strategic Corporate Development.....III-60
1$75
   Groupe Danone – A Key Player.....III-61
B. Market Analytics.....III-61
Table 98: French Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-61
1$200
   Table 99: French Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-621$200
   Table 100: French 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-631$200
   A. Market Analysis.....III-64
Market Overview.....III-64
Strategic Corporate Development.....III-64
Key Players.....III-64
2$150
   B. Market Analytics.....III-66
Table 101: German Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-66
1$200
   Table 102: German Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-671$200
   Table 103: German 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-681$200
   Market Analysis.....III-69
Table 104: Italian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-69
1$200
   Table 105: Italian Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-701$200
   Table 106: Italian 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-711$200
   A. Market Analysis.....III-72
Current and Future Analysis.....III-72
Strategic Corporate Developments.....III-72
1$75
   B. Market Analytics.....III-73
Table 107: UK Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-73
1$200
   Table 108: UK Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-741$200
   Table 109: UK 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-751$200
   Market Analysis.....III-76
Table 110: Spanish Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-76
1$200
   Table 111: Spanish Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-771$200
   Table 112: Spanish 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-781$200
   Market Analysis.....III-79
Table 113: Russian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-79
1$200
   Table 114: Russian Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-801$200
   Table 115: Russian 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-811$200
   A. Market Analysis.....III-82
Current and Future Analysis.....III-82
Nestlé Health Science S.A (Switzerland) – A Key Player.....III-82
1$75
   B. Market Analytics.....III-83
Table 116: Rest of Europe Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-83
1$200
   Table 117: Rest of Europe Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-841$200
   Table 118: Rest of Europe 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-851$200
   A. Market Analysis.....III-86
Market Overview.....III-86
Rising Cases of Diabetes Mellitus: Opportunity for Clinical Nutrition Market in
  Asia-Pacific.....III-86
1$75
   Table 119: Diabetes and Population Statistics in Western Pacific (2015 & 2040) (includes corresponding Graph/Chart).....III-871$200
   Table 120: Diabetes Statistics in Western Pacific (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-881$200
   Table 121: Diabetes and Population Statistics in South East Asia (2015 & 2040) (includes corresponding Graph/Chart).....III-891$200
   Table 122: Diabetes Statistics in South East Asia (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-901$200
   B. Market Analytics.....III-91
Table 123: Asia-Pacific Recent Past, Current and Future Analysis for Clinical Nutrition Products by Geographic Region - Australia, China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-91
1$200
   Table 124: Asia-Pacific Historic Review for Clinical Nutrition Products by Geographic Region - Australia, China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-921$200
   Table 125: Asia-Pacific 14-Year Perspective for Clinical Nutrition Products by Geographic Region - Percentage Breakdown of Dollar Sales for Australia, China, India and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-931$200
   Table 126: Asia-Pacific Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-941$200
   Table 127: Asia-Pacific Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-951$200
   Table 128: Asia-Pacific 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-961$200
   A. Market Analysis.....III-97
Current and Future Analysis.....III-97
Home Enteral Nutrition in New South Wales.....III-97
1$75
   B. Market Analytics.....III-98
Table 129: Australian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-98
1$200
   Table 130: Australian Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-991$200
   Table 131: Australian 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-1001$200
   A. Market Analysis.....III-101
Market Overview.....III-101
Parenteral Nutrition Market: An Insight.....III-101
Competitive Scenario.....III-101
1$75
   Table 132: Leading Suppliers of Enteral Nutrition Preparations in China (2015): Percentage Breakdown of Value Sales for Huarui Pharmaceutical, Nutricia and Others (includes corresponding Graph/Chart).....III-102
Huarui Pharmaceutical Co., Ltd. - A Key Player.....III-102
1$200
   B. Market Analytics.....III-103
Table 133: Chinese Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-103
1$200
   Table 134: Chinese Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1041$200
   Table 135: Chinese 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-1051$200
   A. Market Analysis.....III-106
Current and Future Analysis.....III-106
Ready-to-Use Therapeutic Food to Treat Severe Acute Malnutrition in India.....III-106
1$75
   Table 136: Percentage Share Breakdown of Cost Composition of Ingredients Required for the Production of RUTF (includes corresponding Graph/Chart).....III-107
Key Players.....III-107
1$200
   B. Market Analytics.....III-108
Table 137: Indian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-108
1$200
   Table 138: Indian Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1091$200
   Table 139: Indian 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-1101$200
   A. Market Analysis.....III-111
Current and Future Analysis.....III-111
Strategic Corporate Developments.....III-111
1$75
   B. Market Analytics.....III-112
Table 140: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-112
1$200
   Table 141: Rest of Asia-Pacific Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1131$200
   Table 142: Rest of Asia-Pacific 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-1141$200
   A. Market Analysis.....III-115
Current and Future Analysis.....III-115
Increasing Incidence of Chronic Conditions: Positive Growth Prospects.....III-115
1$75
   Table 143: Diabetes and Population Statistics in Middle East and North Africa (2015 & 2040) (includes corresponding Graph/Chart).....III-1161$200
   Table 144: Diabetes Statistics in Middle East and North Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-1171$200
   Table 145: African Diabetes and Population Statistics (2015 & 2040) (includes corresponding Graph/Chart).....III-1181$200
   Table 146: Diabetes Statistics in Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-1191$200
   B. Market Analytics.....III-120
Table 147: Middle East & Africa Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-120
1$200
   Table 148: Middle East & Africa Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1211$200
   Table 149: Middle East & Africa 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-1221$200
   A. Market Analysis.....III-123
Current and Future Analysis.....III-123
Rising Incidence of Diabetes in Latin America – Opportunity Indicator.....III-123
1$75
   Table 150: Diabetes Statistics in South & Central America (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-1241$200
   B. Market Analytics.....III-125
Table 151: Latin American Recent Past, Current and Future Analysis for Clinical Nutrition Products by Geographic Region - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-125
1$200
   Table 152: Latin American Historic Review for Clinical Nutrition Products by Geographic Region - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1261$200
   Table 153: Latin American 14-Year Perspective for Clinical Nutrition Products by Geographic Region - Percentage Breakdown of Dollar Sales for Brazil, Mexico and Rest of Latin America Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-1271$200
   Table 154: Latin American Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-1281$200
   Table 155: Latin American Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1291$200
   Table 156: Latin American 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-1301$200
   Market Analysis.....III-131
Table 157: Brazilian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-131
1$200
   Table 158: Brazilian Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1321$200
   Table 159: Brazilian 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-1331$200
   Market Analysis.....III-134
Table 160: Mexican Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-134
1$200
   Table 161: Mexican Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1351$200
   Table 162: Mexican 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-1361$200
   A. Market Analysis.....III-137
Current and Future Analysis.....III-137
Strategic Corporate Developments.....III-137
1$75
   B. Market Analytics.....III-138
Table 163: Rest of Latin America Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-138
1$200
   Table 164: Rest of Latin America Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1391$200
   Table 165: Rest of Latin America 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-1401$200
  
Total Companies Profiled: 65 (including Divisions/Subsidiaries - 84)

Region/Country Players

The United States 27 Canada 1 Japan 5 Europe 29 France 5 Germany 5 The United Kingdom 4 Italy 1 Spain 1 Rest of Europe 13 Asia-Pacific (Excluding Japan) 20 Latin America 2
Click here to request a full table of contents and more details on this project.